It has been found that nAChR subunits displayed different protein expression in different tumour sites promoting tumour progression, such as CHRNA1, which increased protein expression in the hypopharynx, larynx, and advanced tumours, but decreased in oropharynx tumours [33]. This evidence concerns the gene CHRNA1 and neoplasm.